These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2228022)

  • 41. Prophylaxis and treatment of newborn endotoxic shock with anti-lipid A monoclonal antibodies.
    Goto M; Zeller WP; Hurley RM; Jong JS; Lee CH
    Circ Shock; 1991 Sep; 35(1):60-4. PubMed ID: 1742861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the interaction between murine tumour necrosis factor and monoclonal antibodies.
    Ameloot P; Fiers W; Buurman WA; de Baetselier P; Brouckaert P
    Cytokine; 2002 May; 18(3):158-63. PubMed ID: 12126652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoclonal antibodies to human tumor necrosis factor alpha: in vitro and in vivo application.
    Möller A; Emling F; Blohm D; Schlick E; Schollmeier K
    Cytokine; 1990 May; 2(3):162-9. PubMed ID: 1716486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel monoclonal human IgM autoantibody which binds recombinant human and mouse tumor necrosis factor-alpha.
    Boyle P; Lembach KJ; Wetzel GD
    Cell Immunol; 1993 Dec; 152(2):556-68. PubMed ID: 7504981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production and characterization of monoclonal antibodies to human tumor necrosis factor.
    Hirai M; Okamura N; Terano Y; Tsujimoto M; Nakazato H
    J Immunol Methods; 1987 Jan; 96(1):57-62. PubMed ID: 3805735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The B5 monoclonal human autoantibody binds to cell surface TNF alpha on human lymphoid cells and cell lines and appears to recognize a novel epitope.
    Boyle P; Lembach KJ; Wetzel GD
    Cell Immunol; 1993 Dec; 152(2):569-81. PubMed ID: 7504982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock.
    Suitters AJ; Foulkes R; Opal SM; Palardy JE; Emtage JS; Rolfe M; Stephens S; Morgan A; Holt AR; Chaplin LC
    J Exp Med; 1994 Mar; 179(3):849-56. PubMed ID: 8113678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An enzyme immunoassay for human lymphotoxin.
    Tada H; Toyoda Y; Okazaki K; Nakata M; Iwasa S
    J Immunoassay; 1989; 10(1):93-105. PubMed ID: 2654187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of experimental metastasis by tumor necrosis factor.
    Orosz P; Echtenacher B; Falk W; Rüschoff J; Weber D; Männel DN
    J Exp Med; 1993 May; 177(5):1391-8. PubMed ID: 8478614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigenic structure of human tumour necrosis factor: recognition of distinct regions of TNF alpha by different tumour cell receptors.
    Rathjen DA; Cowan K; Furphy LJ; Aston R
    Mol Immunol; 1991; 28(1-2):79-86. PubMed ID: 1707138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production and characterization of two monoclonal antibodies to bovine tumour necrosis factor alpha (TNF-alpha) and their cross-reactivity with ovine TNF-alpha.
    Kwong LS; Thom M; Sopp P; Rocchi M; Wattegedera S; Entrican G; Hope JC
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):320-4. PubMed ID: 20207016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Development of an anti-rTNF-alpha chimeric antibody].
    Lin Z; Li Y; Hu MR; Yu JY; Shen BF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 May; 19(3):252-4. PubMed ID: 15155085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal antibodies against human recombinant tumor necrosis factor: prevention of endotoxic shock.
    Shimamoto Y; Chen RL; Bollon A; Chang A; Khan A
    Immunol Lett; 1988 Apr; 17(4):311-7. PubMed ID: 3372010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal antibody to mouse lipopolysaccharide receptor protects mice against the lethal effects of endotoxin.
    Morrison DC; Silverstein R; Bright SW; Chen TY; Flebbe LM; Lei MG
    J Infect Dis; 1990 Nov; 162(5):1063-8. PubMed ID: 1700023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibody.
    Rathjen DA; Furphy LJ; Aston R
    Br J Cancer; 1992 Jun; 65(6):852-6. PubMed ID: 1377483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of reactivity of monoclonal antibody (3F2) to trimeric tumor necrosis factor (TNF-alpha) with that to monomeric TNF-alpha.
    Saijo S; Watanabe N; Kobayashi Y
    J Biochem; 1995 Jul; 118(1):28-32. PubMed ID: 8537321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method.
    Tierrablanca-Sánchez L; Pérez Medina Martínez V; Ramírez Ibañez ND; Pérez Ramírez NO; Flores Ortiz FL; Medina-Rivero E
    J Vis Exp; 2017 Sep; (127):. PubMed ID: 28994757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumour necrosis factor and septic shock.
    Waage A
    Lancet; 1998 Feb; 351(9102):603. PubMed ID: 9492815
    [No Abstract]   [Full Text] [Related]  

  • 59. Dichotomous Role of Tumor Necrosis Factor in Pulmonary Barrier Function and Alveolar Fluid Clearance.
    Lucas R; Hadizamani Y; Enkhbaatar P; Csanyi G; Caldwell RW; Hundsberger H; Sridhar S; Lever AA; Hudel M; Ash D; Ushio-Fukai M; Fukai T; Chakraborty T; Verin A; Eaton DC; Romero M; Hamacher J
    Front Physiol; 2021; 12():793251. PubMed ID: 35264975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi.
    Truyens C; Torrico F; Lucas R; De Baetselier P; Buurman WA; Carlier Y
    Infect Immun; 1999 Nov; 67(11):5579-86. PubMed ID: 10531203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.